Myrtelle Announces Presentation of Positive 12-month Post Treatment Data in its First-in-Human Clinical Study of rAAV-Olig001-ASPA Gene Therapy at the 2023 Cell & Gene Meeting on the Mesa held by the Alliance for Regenerative Medicine
Wakefield, Mass., October 10, 2023 – Myrtelle Inc. (“Myrtelle” or the “Company”), a gene therapy company focused on developing transformative treatments for neurodegenerative diseases…
Article Date
October 10, 2023
This article is featured on another website.
Go to article
May 1, 2026
Headed to ASCO 2026? Meet the HiRO Team in Chicago
HiRO will be Attending the ASCO Annual Meeting: Advancing Oncology Innovation | Visit Us at…
May 1, 2026
Headed to ASCO 2026? Meet the HiRO Team in Chicago
HiRO will be Attending the ASCO Annual Meeting: Advancing Oncology Innovation | Visit Us at…
March 26, 2026
pharmaphorum – BIO‑Europe Spring 2026: In conversation with Marjorie Sidhoum, Vice President of Business Development and Corporate Communications at Kainova Therapeutics
March 26, 2026